GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2367.35 and 2433.55
| Intraday Target 1 | 2313.3 |
| Intraday Target 2 | 2355.2 |
| Intraday Target 3 | 2379.5 |
| Intraday Target 4 | 2421.4 |
| Intraday Target 5 | 2445.7 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 12 January 2026 | 2397.10 (1.05%) | 2372.00 | 2337.60 - 2403.80 | 0.3988 times | Fri 09 January 2026 | 2372.10 (-1.11%) | 2390.00 | 2350.00 - 2404.00 | 0.73 times | Thu 08 January 2026 | 2398.70 (-2.48%) | 2455.00 | 2386.80 - 2455.30 | 0.3938 times | Wed 07 January 2026 | 2459.80 (-0.95%) | 2483.30 | 2448.00 - 2528.00 | 1.3966 times | Tue 06 January 2026 | 2483.30 (1.1%) | 2456.00 | 2437.20 - 2504.00 | 0.4092 times | Mon 05 January 2026 | 2456.20 (-1.11%) | 2484.90 | 2452.00 - 2484.90 | 0.3964 times | Fri 02 January 2026 | 2483.80 (1.14%) | 2461.30 | 2443.90 - 2487.70 | 0.2463 times | Thu 01 January 2026 | 2455.90 (-0.72%) | 2476.00 | 2442.50 - 2476.00 | 0.3657 times | Wed 31 December 2025 | 2473.60 (3.75%) | 2419.40 | 2382.00 - 2482.50 | 1.0232 times | Tue 30 December 2025 | 2384.20 (-3.76%) | 2462.20 | 2362.60 - 2468.40 | 4.6399 times | Mon 29 December 2025 | 2477.40 (0.53%) | 2483.00 | 2445.00 - 2487.50 | 0.459 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2367.35 and 2433.55
| Weekly Target 1 | 2313.3 |
| Weekly Target 2 | 2355.2 |
| Weekly Target 3 | 2379.5 |
| Weekly Target 4 | 2421.4 |
| Weekly Target 5 | 2445.7 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 12 January 2026 | 2397.10 (1.05%) | 2372.00 | 2337.60 - 2403.80 | 0.1086 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.9054 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 1.8331 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.4354 times | Fri 19 December 2025 | 2529.00 (-2.76%) | 2587.70 | 2506.70 - 2608.90 | 0.7994 times | Fri 12 December 2025 | 2600.80 (2.17%) | 2545.60 | 2491.00 - 2635.00 | 1.251 times | Fri 05 December 2025 | 2545.60 (-0.93%) | 2551.00 | 2461.10 - 2582.50 | 1.2963 times | Fri 28 November 2025 | 2569.50 (2.87%) | 2497.90 | 2404.20 - 2585.10 | 1.0486 times | Fri 21 November 2025 | 2497.90 (0.75%) | 2491.70 | 2471.40 - 2532.60 | 0.9767 times | Fri 14 November 2025 | 2479.40 (-4.19%) | 2587.00 | 2467.50 - 2590.60 | 1.3455 times | Fri 07 November 2025 | 2587.90 (-1.17%) | 2644.00 | 2479.00 - 2694.00 | 1.1738 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2272.15 and 2462.55
| Monthly Target 1 | 2230.5 |
| Monthly Target 2 | 2313.8 |
| Monthly Target 3 | 2420.9 |
| Monthly Target 4 | 2504.2 |
| Monthly Target 5 | 2611.3 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 12 January 2026 | 2397.10 (-3.09%) | 2476.00 | 2337.60 - 2528.00 | 0.1898 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 0.8761 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.7308 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.4745 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.7559 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.0461 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.6387 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.2779 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.2947 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.7155 times | Fri 28 March 2025 | 2880.35 (16.36%) | 2485.00 | 2390.05 - 2988.00 | 1.193 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2272.15 and 2462.55
| Yearly Target 1 | 2230.5 |
| Yearly Target 2 | 2313.8 |
| Yearly Target 3 | 2420.9 |
| Yearly Target 4 | 2504.2 |
| Yearly Target 5 | 2611.3 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 12 January 2026 | 2397.10 (-3.09%) | 2476.00 | 2337.60 - 2528.00 | 0.0277 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.7058 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.3004 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2788 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7428 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9908 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.1057 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.473 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2405 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1345 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1348 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
And this trend seems to be continuing further.Price is below an important level of 2443.85 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.
Munafa value: 50 as on Mon 12 January 2026
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2483 and price is deviating by 63 points
Upper Bollinger band is at 2607 and lower is at 2358, while middle bands are at 2421 and 2545
Price is rising
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2416.09 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2422.2 |
| 12 day DMA | 2442.2 |
| 20 day DMA | 2482.32 |
| 35 day DMA | 2505.65 |
| 50 day DMA | 2517.09 |
| 100 day DMA | 2634.81 |
| 150 day DMA | 2802.59 |
| 200 day DMA | 2833.29 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2412.46 | 2420.14 | 2444.15 |
| 12 day EMA | 2443.86 | 2452.36 | 2466.95 |
| 20 day EMA | 2467.96 | 2475.42 | 2486.29 |
| 35 day EMA | 2495.17 | 2500.94 | 2508.52 |
| 50 day EMA | 2520.11 | 2525.13 | 2531.37 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2422.2 | 2434.02 | 2456.36 |
| 12 day SMA | 2442.2 | 2449.68 | 2460.36 |
| 20 day SMA | 2482.32 | 2492.5 | 2505 |
| 35 day SMA | 2505.65 | 2508.53 | 2512.44 |
| 50 day SMA | 2517.09 | 2521.59 | 2527 |
| 100 day SMA | 2634.81 | 2638.78 | 2642.76 |
| 150 day SMA | 2802.59 | 2809.53 | 2816.82 |
| 200 day SMA | 2833.29 | 2835.98 | 2838.42 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 42.51
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 42.74
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance


